155
Participants
Start Date
September 30, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
CardioGen-82
CardioGen-82 is not administered to patients in this study, however to be able to qualify for enrollment, the patients must have received CardioGen previously
Bracco Diagnostics, Inc., Princeton
Lead Sponsor
Bracco Diagnostics, Inc
INDUSTRY